PATH vs STAA
Uipath Inc (PATH) versus STAAR Surgical Company (STAA) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported STAA revenue for 2024-12-27 was $313.9M. Net income was -$20.2M. Revenue was down 2.6% from 2023-12-29 to 2024-12-27. STAA currently screens at market cap $1.45B.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. STAA currently screens at market cap $1.45B.
Not investment advice. Open the PATH and STAA stock pages for the full models.
Not investment advice.